An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer
Abstract The prostate-specific membrane antigen (PSMA) has been demonstrated in numerous studies to be expressed specifically on prostate carcinoma cells and on the neovasculature of several other cancer entities. However, the simultaneous expression of PSMA on both, tumor cells as well as tumor ves...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2021
|
| In: |
EMBO molecular medicine
Year: 2021, Jahrgang: 13, Heft: 2, Pages: 1-15 |
| ISSN: | 1757-4684 |
| DOI: | 10.15252/emmm.201911902 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.15252/emmm.201911902 Verlag, kostenfrei, Volltext: https://www.embopress.org/doi/full/10.15252/emmm.201911902 
|
| Verfasserangaben: | Latifa Zekri, Fabian Vogt, Lukas Osburg, Stefanie Müller, Joseph Kauer, Timo Manz, Martin Pflügler, Andreas Maurer, Jonas S Heitmann, Ilona Hagelstein, Melanie Märklin, Sebastian Hörner, Tilmann Todenhöfer, Carsten Calaminus, Arnulf Stenzl, Bernd Pichler, Christian la Fougère, Marc A Schneider, Hans-Georg Rammensee, Lars Zender, Bence Sipos, Helmut R Salih & Gundram Jung |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1869421167 | ||
| 003 | DE-627 | ||
| 005 | 20250127090454.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231106s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.15252/emmm.201911902 |2 doi | |
| 035 | |a (DE-627)1869421167 | ||
| 035 | |a (DE-599)KXP1869421167 | ||
| 035 | |a (OCoLC)1425217822 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Zekri, Latifa |e VerfasserIn |0 (DE-588)1308837801 |0 (DE-627)1869420837 |4 aut | |
| 245 | 1 | 3 | |a An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer |c Latifa Zekri, Fabian Vogt, Lukas Osburg, Stefanie Müller, Joseph Kauer, Timo Manz, Martin Pflügler, Andreas Maurer, Jonas S Heitmann, Ilona Hagelstein, Melanie Märklin, Sebastian Hörner, Tilmann Todenhöfer, Carsten Calaminus, Arnulf Stenzl, Bernd Pichler, Christian la Fougère, Marc A Schneider, Hans-Georg Rammensee, Lars Zender, Bence Sipos, Helmut R Salih & Gundram Jung |
| 264 | 1 | |c 2021 | |
| 300 | |b Illustrationen | ||
| 300 | |a 15 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published: 29 December 2020 | ||
| 500 | |a Gesehen am 06.11.2023 | ||
| 520 | |a Abstract The prostate-specific membrane antigen (PSMA) has been demonstrated in numerous studies to be expressed specifically on prostate carcinoma cells and on the neovasculature of several other cancer entities. However, the simultaneous expression of PSMA on both, tumor cells as well as tumor vessels remains unclear, even if such ?dual? expression would constitute an important asset to facilitate sufficient influx of effector cells to a given tumor site. We report here on the generation of a PSMA antibody, termed 10B3, which exerts superior dual reactivity on sections of prostate carcinoma and squamous cell carcinoma of the lung. 10B3 was used for the construction of T-cell recruiting bispecific PSMAxCD3 antibodies in Fab- and IgG-based formats, designated Fabsc and IgGsc, respectively. In vitro, both molecules exhibited comparable activity. In contrast, only the larger IgGsc molecule induced complete and durable elimination of established tumors in humanized mice due to favorable pharmacokinetic properties. Upon treatment of three patients with metastasized prostate carcinoma with the IgGsc reagent, marked activation of T cells and rapid reduction of elevated PSA levels were observed. | ||
| 650 | 4 | |a bispecific antibody | |
| 650 | 4 | |a immunotherapy | |
| 650 | 4 | |a lung cancer | |
| 650 | 4 | |a prostate cancer | |
| 650 | 4 | |a PSMA | |
| 700 | 1 | |8 1\p |a Vogt, Fabian |d 1985- |e VerfasserIn |0 (DE-588)1187667463 |0 (DE-627)1666593400 |4 aut | |
| 700 | 1 | |a Osburg, Lukas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Müller, Stefanie |e VerfasserIn |4 aut | |
| 700 | 1 | |8 2\p |a Kauer, Joseph |d 1992- |e VerfasserIn |0 (DE-588)1161466134 |0 (DE-627)102475524X |0 (DE-576)50654382X |4 aut | |
| 700 | 1 | |a Manz, Timo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pflügler, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Maurer, Andreas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heitmann, Jonas S |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hagelstein, Ilona |e VerfasserIn |4 aut | |
| 700 | 1 | |a Märklin, Melanie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hörner, Sebastian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Todenhöfer, Tilman Wolfgang |d 1982- |e VerfasserIn |0 (DE-588)140005579 |0 (DE-627)614757738 |0 (DE-576)314152288 |4 aut | |
| 700 | 1 | |a Calaminus, Carsten |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stenzl, Arnulf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pichler, Bernd |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fougère, Christian la |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schneider, Marc |d 1982- |e VerfasserIn |0 (DE-588)140634401 |0 (DE-627)620239948 |0 (DE-576)319208095 |4 aut | |
| 700 | 1 | |a Rammensee, Hans-Georg |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zender, Lars |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sipos, Bence |e VerfasserIn |4 aut | |
| 700 | 1 | |8 3\p |a Salih, Helmut R. |d 1970- |e VerfasserIn |0 (DE-588)120086565 |0 (DE-627)080436919 |0 (DE-576)180103148 |4 aut | |
| 700 | 1 | |a Jung, Gundram |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a European Molecular Biology Organization |t EMBO molecular medicine |d [London] : Nature Publishing Group UK, 2009 |g 13(2021), 2, Artikel-ID e11902, Seite 1-15 |h Online-Ressource |w (DE-627)594772761 |w (DE-600)2485479-7 |w (DE-576)305355961 |x 1757-4684 |7 nnas |
| 773 | 1 | 8 | |g volume:13 |g year:2021 |g number:2 |g elocationid:e11902 |g pages:1-15 |g extent:15 |a An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer |
| 856 | 4 | 0 | |u https://doi.org/10.15252/emmm.201911902 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.embopress.org/doi/full/10.15252/emmm.201911902 |x Verlag |z kostenfrei |3 Volltext |
| 883 | |8 1\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 2\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 3\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20231106 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 140634401 |a Schneider, Marc |m 140634401:Schneider, Marc |d 910000 |d 950000 |d 950900 |e 910000PS140634401 |e 950000PS140634401 |e 950900PS140634401 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 18 | ||
| 999 | |a KXP-PPN1869421167 |e 4403049451 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer","title_sort":"IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer"}],"person":[{"family":"Zekri","given":"Latifa","role":"aut","display":"Zekri, Latifa"},{"display":"Vogt, Fabian","family":"Vogt","given":"Fabian","role":"aut"},{"family":"Osburg","given":"Lukas","role":"aut","display":"Osburg, Lukas"},{"display":"Müller, Stefanie","family":"Müller","given":"Stefanie","role":"aut"},{"display":"Kauer, Joseph","family":"Kauer","role":"aut","given":"Joseph"},{"family":"Manz","given":"Timo","role":"aut","display":"Manz, Timo"},{"display":"Pflügler, Martin","role":"aut","given":"Martin","family":"Pflügler"},{"role":"aut","given":"Andreas","family":"Maurer","display":"Maurer, Andreas"},{"given":"Jonas S","role":"aut","family":"Heitmann","display":"Heitmann, Jonas S"},{"display":"Hagelstein, Ilona","family":"Hagelstein","role":"aut","given":"Ilona"},{"family":"Märklin","given":"Melanie","role":"aut","display":"Märklin, Melanie"},{"family":"Hörner","role":"aut","given":"Sebastian","display":"Hörner, Sebastian"},{"display":"Todenhöfer, Tilman Wolfgang","family":"Todenhöfer","given":"Tilman Wolfgang","role":"aut"},{"display":"Calaminus, Carsten","role":"aut","given":"Carsten","family":"Calaminus"},{"display":"Stenzl, Arnulf","family":"Stenzl","given":"Arnulf","role":"aut"},{"display":"Pichler, Bernd","family":"Pichler","given":"Bernd","role":"aut"},{"display":"Fougère, Christian la","given":"Christian la","role":"aut","family":"Fougère"},{"display":"Schneider, Marc","family":"Schneider","role":"aut","given":"Marc"},{"given":"Hans-Georg","role":"aut","family":"Rammensee","display":"Rammensee, Hans-Georg"},{"family":"Zender","given":"Lars","role":"aut","display":"Zender, Lars"},{"role":"aut","given":"Bence","family":"Sipos","display":"Sipos, Bence"},{"display":"Salih, Helmut R.","given":"Helmut R.","role":"aut","family":"Salih"},{"given":"Gundram","role":"aut","family":"Jung","display":"Jung, Gundram"}],"language":["eng"],"physDesc":[{"noteIll":"Illustrationen","extent":"15 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"id":{"doi":["10.15252/emmm.201911902"],"eki":["1869421167"]},"recId":"1869421167","name":{"displayForm":["Latifa Zekri, Fabian Vogt, Lukas Osburg, Stefanie Müller, Joseph Kauer, Timo Manz, Martin Pflügler, Andreas Maurer, Jonas S Heitmann, Ilona Hagelstein, Melanie Märklin, Sebastian Hörner, Tilmann Todenhöfer, Carsten Calaminus, Arnulf Stenzl, Bernd Pichler, Christian la Fougère, Marc A Schneider, Hans-Georg Rammensee, Lars Zender, Bence Sipos, Helmut R Salih & Gundram Jung"]},"note":["Published: 29 December 2020","Gesehen am 06.11.2023"],"relHost":[{"title":[{"title_sort":"EMBO molecular medicine","title":"EMBO molecular medicine"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"corporate":[{"role":"aut","display":"European Molecular Biology Organization"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"doi":["10.1002/(ISSN)1757-4684"],"issn":["1757-4684"],"zdb":["2485479-7"],"eki":["594772761"]},"origin":[{"publisherPlace":"[London] ; Heidelberg ; Weinheim","publisher":"Nature Publishing Group UK ; EMBO Press ; Wiley-VCH","dateIssuedDisp":"[2009]-"}],"disp":"European Molecular Biology OrganizationEMBO molecular medicine","name":{"displayForm":["European Molecular Biology Organization (EMBO)"]},"recId":"594772761","pubHistory":["Vol. 1, No. 1 (Apr 1, 2009)-"],"note":["Gesehen am 5. November 2022","Fortsetzung der Druck-Ausgabe"],"part":{"extent":"15","text":"13(2021), 2, Artikel-ID e11902, Seite 1-15","volume":"13","pages":"1-15","year":"2021","issue":"2"}}]} | ||
| SRT | |a ZEKRILATIFIGGBASEDBI2021 | ||